Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for prevention of pediatric emergence delirium after dental treatment under general anesthesia
ChiCTR2100042575Phase 4Recruiting
- Sponsor
- Shanghai Stomatological Hospital, Fudan University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Shanghai Stomatological Hospital, Fudan University. Primary endpoint: Pediatric Anesthesia Emergence Delirium (PAED) scale. Started Jan 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2100042575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042575.